Antiviral Drugs - Portugal

Portugal

Highlights

In Portugal, the projected revenue for the Antiviral Drugs market is expected to reach US$93.06m in 2024.
The market is anticipated to experience a steady annual growth rate (CAGR 2024-2029) of 2.01%, leading to a market volume of US$102.80m by 2029.
When compared globally, United States is projected to generate the highest revenue, amounting to US$30.64bn in 2024.
In Portugal, the demand for antiviral drugs has surged due to the increasing prevalence of viral infections and the government's efforts to strengthen healthcare infrastructure.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Antiviral Drugs market in Portugal has seen significant growth in recent years, driven by various factors such as increasing prevalence of viral infections, rising awareness about antiviral drugs, and advancements in drug development technologies.

Customer preferences: The customers in Portugal are increasingly preferring antiviral drugs due to the rising incidence of viral infections such as HIV, hepatitis, and influenza. The increasing awareness about the benefits of antiviral drugs in treating these infections is also contributing to the growth of the market.

Trends in the market: One of the major trends in the Antiviral Drugs market in Portugal is the increasing demand for combination therapies. Combination therapies involve the use of two or more antiviral drugs to treat a single infection. This approach has been found to be more effective in treating viral infections and reducing the risk of drug resistance.Another trend in the market is the growing focus on developing drugs with fewer side effects. Antiviral drugs are known to cause a range of side effects, which can be severe in some cases. Therefore, drug developers are focusing on developing drugs that are more tolerable and have fewer side effects.

Local special circumstances: The Antiviral Drugs market in Portugal is also influenced by local factors such as the healthcare system and regulatory environment. The healthcare system in Portugal is well-developed and provides universal coverage to all citizens. This has led to a high demand for antiviral drugs, as they are readily available to patients.Additionally, the regulatory environment in Portugal is favorable for the development and commercialization of antiviral drugs. The country has a well-established regulatory framework for drug approval and a streamlined process for clinical trials.

Underlying macroeconomic factors: The growth of the Antiviral Drugs market in Portugal is also influenced by macroeconomic factors such as GDP growth and healthcare expenditure. Portugal has seen steady GDP growth in recent years, which has led to increased healthcare expenditure and investment in healthcare infrastructure. This has created a favorable environment for the development and commercialization of antiviral drugs.In conclusion, the Antiviral Drugs market in Portugal is expected to continue its growth trajectory in the coming years, driven by factors such as increasing prevalence of viral infections, rising awareness about antiviral drugs, and favorable regulatory environment. The market is also likely to see further trends such as the increasing use of combination therapies and the development of drugs with fewer side effects.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.